![William Andrews](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 72 110 $ am 31.05.2026
William T.
Andrews is the founder of The Aletheia Group LLC.
Dr. Andrews is Chief Medical Officer at Catalyst Pharmaceuticals, Inc. and Chief Medical Officer at Rafarma Pharmaceuticals, Inc., both starting in 2025.
Formerly, Dr. Andrews was President & Chief Executive Officer at Lighthouse Biosciences Inc., Senior Vice President-Business Development at Aegerion Pharmaceuticals, Inc. from 2014 to 2016, Chief Medical Officer at Flexion Therapeutics, Inc. in 2021, Chief Medical Officer at Akcea Therapeutics, Inc., and Chief Medical Officer at Acer Therapeutics, Inc. from 2017 to 2020.
Dr. Andrews completed undergraduate studies at Harvard University and earned a doctorate from Yale School of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 03.06.2026 | 2.309 ( 0 % ) | 72 110 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2025 |
| RAFARMA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.06.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
| FLEXION THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 19.11.2021 |
| ACER THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 08.07.2020 |
| AEGERION PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2014 |
The Aletheia Group LLC | Gründer | - |
Lighthouse Biosciences Inc.
 Lighthouse Biosciences Inc. BiotechnologyHealth Technology Manufactures medical diagnostic instruments | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Catalyst Pharmaceuticals, Inc.
 Catalyst Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets novel medicines for patients living with rare diseases | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rafarma Pharmaceuticals, Inc.
 Rafarma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drugs, generic antibiotics, vaccines & specialty pharmaceutical products | Health Technology |
Lighthouse Biosciences Inc.
Lighthouse Biosciences Inc. BiotechnologyHealth Technology Manufactures medical diagnostic instruments | Health Technology |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cardiometabolic lipid disorders | Health Technology |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
The Aletheia Group LLC |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
